High Intensity Focused Ultrasound in Prostate Cancer

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also investigate the change in participant quality of life after HIFU therapy as compared to before HIFU therapy.

Trial Details

NCT ID

NCT06402357

Phase

PHASE2

Sponsor

University of Florida

Status

RECRUITING

Cancer Type

Prostate Cancer

Interventions

Focal One high intensity focused ultrasound device

Locations (sample)

Gainesville, Florida, United States|29.65163,-82.32483

Key Eligibility Criteria

Patient has elected to undergo focal high intensity focused ultrasound therapy for radiorecurrent prostate cancer
Males who are ≥ 18 years of age
Eastern Cooperative Oncology Group Performance Status of 0-3
A history of prostate cancer treated with radiation therapy +/- hormone therapy

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →